Currently used doses of omeprazole in Zollinger-Ellison syndrome are too high
Authors:
- Joseph R. PisegnaJPJoseph R. Pisegna
- Vitaly A. FishbeynVFVitaly A. Fishbeyn
- Richard V. BenyaRBRichard V. Benya
- Kathryn M. FeigenbaumKFKathryn M. Feigenbaum
- Pamela D. KoviackPKPamela D. Koviack
- Robert T. JensenRJRobert T. Jensen
- 1 November 1992
- journal article
- Published by Elsevier in Gastroenterology
- Vol. 103 (5) , 1498-1508
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Omeprazole Drug Interaction StudiesClinical Pharmacokinetics, 1991
- OmeprazoleDrugs, 1991
- Use of omeprazole in patients with Zollinger-Ellison syndromeDigestive Diseases and Sciences, 1991
- Long-term efficacy and safety of omeprazole in patients with Zollinger-Ellison syndrome: A prospective studyGastroenterology, 1989
- Gastric endocrine cell behavior in Zollinger-Ellison patients upon long-term potent antisecretory treatmentGastroenterology, 1989
- Omeprazole in the Treatment of Zollinger-Ellison Syndrome and Histamine H2-Antagonist Refractory UlcersDigestion, 1989
- Effects of Omeprazole on Acid Secretion and Acid-Related Symptoms in Patients with Zollinger-Ellison SyndromeScandinavian Journal of Gastroenterology, 1989
- Effect of single and repeated intravenous doses of omeprazole on pentagastrin stimulated gastric acid secretion and pharmacokinetics in man.Gut, 1988
- OmeprazoleDrugs, 1986
- Substituted benzimidazoles inhibit gastric acid secretion by blocking (H+ + K+) ATPaseNature, 1981